BioSpace News Archive

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to provide a corporate update, and report financial and operational highlights for the first quarter ended September 30, 2020.

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Wednesday, December 2, 2020, at 8:00 a.m. ET.

Antimicrobial resistance is a growing public health threat in Canada and worldwide.

McKesson Corporation (NYSE:MCK) today announced that the company has appointed Dr. Kelvin A. Baggett to the newly created role of chief impact officer, effective November 30, 2020.

LifeLabs is pleased to report results of over 800,000 COVID-19 molecular diagnostic tests for Canadians and their health care providers.

Neurocrine Biosciences, Inc. announced that Neurocrine Biosciences management will present at the following investor conferences:.

Alvotech Announces That the U.S. FDA and EMA Have Accepted Regulatory Submissions for AVT02, a Proposed Biosimilar to HUMIRA® (adalimumab) Alvotech is developing AVT02 as a proposed biosimilar to HUMIRA® (adalimumab) with high concentration (100mg/mL) dosage forms AVT02 is highly similar to its reference product in terms of structure and function The pharmacokinetic (PK) similarity study for AVT02 (AVT02-GL-101) has met its primary objectives

Reify Health , provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced that Amgen, a leading global biopharmaceutical company, will expand adoption of StudyTeam across the biopharma’s global research portfolio. Initially, Amgen deployed

JADAK, a business unit of Novanta Corporation, announces the release of the ThingMagic M3e LF/HF RFID Secure Module enabled with the ability to read iClass and Prox encrypted badges in medical devices.

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, will demonstrate the FDR D-EVO III, an industry-first, glass-free digital radiography (DR) detector with Irradiated Side Sampling (ISS) technology, and the latest additions to Fujifilm’s Clinica family digital x-ray suites - FDR Clinica X OTC and FDR Clinica FS – during the 2020 Radiological Society of North America (RSNA) annual meeting.